December 29, 2023 · Form 4 insider transaction
Reardon Andrew bought 179 shares of Ligand Pharmaceuticals Incorporated at $60.71 per share, a transaction worth $10.9K. The trade was recorded as j and disclosed on an SEC Form 4, filed 6 days after the transaction.
Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).